Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Multiple Sclerosis
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Multiple Sclerosis
    Cannabinoid Spray Receives Regulatory Authorisation in Spain - (DGNews)
    TopAbstracts in Multiple Sclerosis 07/22/2010 - (DGNews)
    TopAbstracts in Multiple Sclerosis 07/08/2010 - (DGNews)
    TopAbstracts in Multiple Sclerosis 06/24/2010 - (DGNews)
    TopAbstracts in Multiple Sclerosis 06/10/2010 - (DGNews)

    News archive

     Recent webcasts/CME - Multiple Sclerosis
    • Optimizing Treatment to Delay Disease Progression and Preserve Cognitive Function: A Review of Established and Emerging Therapies for MS
    • Forging Ahead: What Are the Current Needs and Latest Advances in the Treatment of Multiple Sclerosis?
    • Improving the Understanding and Management of Cognitive Impairment in Multiple Sclerosis
    • The Costs of Multiple Sclerosis: Maximizing the Impact of Treatment on Health and Economic Outcomes
      Multiple Sclerosis: Tempering Disabilities and Decline--Fundamentals for Managed Markets

      Webcasts/CME archive

       Recent cases - Multiple Sclerosis
        Patient With Neuromyelitis Optica And Inflammatory Demyelinating Lesions Comprising Whole Spinal Cord From C2 Level Till Conus: Case Report
        Encephalomyelitis Mimicking Multiple Sclerosis Associated with Chronic Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplantation
        Progressive Primary Form of Multiple Sclerosis: Clinical and Radiological Improvement with Methylprednisolone in Continuous Pulsetherapy in One Case for 16 Years
        Burrowing of Urinary Bladder Wall by the Tip of a Size 22 Fr Silicone Foley Catheter in an Adult Male Patient With Multiple Sclerosis and Suprapubic Cystostomy: Should Caution be Exercised in Using a Size 22 Fr Silicone Foley Catheter for Long-Term Drainage of Neuropathic Bladder?
        Central Auditory Evaluation in Multiple Sclerosis: Case Report

        Cases archive
          




        my personal edition > multiple sclerosis > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Astrocytes in Multiple Sclerosis Plaques May Play Role in Autoimmune Reaction: Presented at ECFS

        By Adrian Burton
        Special to DG News

        SEVILLE, SPAIN -- November 28, 2002 -- Highly reactive astrocytes located in newly developing multiple sclerosis (MS) plaques, and on the rims of established plaques might be responsible for initiating autoimmune reactions.

        "Most people who work on MS focus on microglia as the main type of cell responsible for immunological reactions, but we thought that astrocytes might also be very important, at least in antigen presentation," explained Esther Zeinstra, Neurologist at the University Hospital, Groeningen, The Netherlands, spoking here November 28 at the European Charcot Foundation Symposium.

        "Like microglia, astrocytes express major histocompatibility complex class II molecules on their surface, which are required for cells to present [auto]antigens to T cells," Dr. Zeinstra explained. "But they are not the only thing needed to get a full blown immunological reaction. You also need co-stimulation, but until now it was thought astrocytes did not express co-stimulatory molecules. However, we have found that, in some cases, they do."

        Using white matter samples from 20 MS patients, 10 controls and a further two patients with herpes simplex encephalitis, the Dutch team performed double immunofluorescent staining for microglia and astrocytes and the T cell co-stimulatory molecules B1-7 and B7-2.

        No co-stimulatory molecules were found on astrocytes in samples from herpes simplex encephalitis or control patients. However, some of the astrocytes in samples from the MS patients clearly stained for both co-stimulators. "Not all of them showed this, just the very reactive, very swollen ones in newly formed plaques or on the rims of established plaques. They seem to express them at this point in the disease process," explained Dr. Zeinstra.

        Interestingly, the microglia of the control patients also expressed both major histocompatibility complex class II and the co-stimulatory molecules, raising the question of whether microglia are actually involved in MS at all.

        "Astrocytes are worth looking at further to see whether they have a larger role than we have recognised up to now. If they have, it could open up new therapeutic options," concluded Dr. Zeinstra.



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2010 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send